eCFR Reference Browser

---

title: "21 CFR §860.90"

source: "https://www.ecfr.gov/current/title-21/section-860.90"

title_number: "21"

volume_number: "8"

chapter_number: "Unknown"

subchapter_code: "H"

subchapter_subject: "MEDICAL DEVICES"

part_code: "860"

part_subject: "MEDICAL DEVICE CLASSIFICATION PROCEDURES"

subpart_code: "B"

subpart_subject: "Classification"

section_number: "860.90"

section_subject: "Consultation with panels."

cfr_reference: "21 CFR 860.90"

title_name: "Title 21"

title_subject: "Food and Drugs"

parts_covered: "Parts 800 to 1299"

revised_date: "Revised as of April 1, 2019"

publication_date: "As of April 1, 2019"

contains_description: "Containing a codification of documents of general applicability and future effect"

publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"

---

(a)When the Commissioner is required to consult with a panel concerning a classification under § 860.84, the Commissioner will consult with the panel in one of the following ways:

(1)Consultation by telephone with at least a majority of current voting panel members and, when possible, nonvoting panel members in a telephone or video conference call; or

(2)Discussion at a panel meeting.

(b)The method of consultation chosen by the Commissioner will depend upon the importance and complexity of the subject matter involved and the time available for action. When time and circumstances permit, the Commissioner will consult with a panel through discussion at a panel meeting.

§860.90 - Consultation with panels.